Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashFree Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spyre Therapeutics (SYRE) Exchange Rate Effect (2020 - 2024)

Historic Exchange Rate Effect for Spyre Therapeutics (SYRE) over the last 5 years, with Q4 2024 value amounting to -$15000.0.

  • Spyre Therapeutics' Exchange Rate Effect fell 18333.33% to -$15000.0 in Q4 2024 from the same period last year, while for Sep 2025 it was -$15000.0, marking a year-over-year decrease of 15000.0%. This contributed to the annual value of -$3000.0 for FY2024, which is 11200.0% down from last year.
  • According to the latest figures from Q4 2024, Spyre Therapeutics' Exchange Rate Effect is -$15000.0, which was down 18333.33% from $16000.0 recorded in Q3 2024.
  • In the past 5 years, Spyre Therapeutics' Exchange Rate Effect registered a high of $47000.0 during Q4 2020, and its lowest value of -$72000.0 during Q2 2022.
  • For the 5-year period, Spyre Therapeutics' Exchange Rate Effect averaged around -$3250.0, with its median value being $3500.0 (2021).
  • Over the last 5 years, Spyre Therapeutics' Exchange Rate Effect had its largest YoY gain of 143333.33% in 2022, and its largest YoY loss of 190000.0% in 2022.
  • Quarter analysis of 5 years shows Spyre Therapeutics' Exchange Rate Effect stood at $47000.0 in 2020, then crashed by 93.62% to $3000.0 in 2021, then surged by 1433.33% to $46000.0 in 2022, then crashed by 60.87% to $18000.0 in 2023, then crashed by 183.33% to -$15000.0 in 2024.
  • Its Exchange Rate Effect stands at -$15000.0 for Q4 2024, versus $16000.0 for Q3 2024 and -$4000.0 for Q1 2024.